US equities |
SPCX $171.09 ▲+0.00% MU $1,063.96 ▲+0.00% NVDA $238.90 ▲+0.00% META $741.90 ▲+0.00% AMD $631.75 ▲+0.00% AMZN $251.40 ▲+0.00% SNDK $1,704.16 ▲+0.00% INTC $116.19 ▲+0.00%
FinancialContent

Apollo Endosurgery, Inc. - Common Stock (NQ:APEN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apollo Endosurgery, Inc. - Common Stock

< Previous 1 2 3 Next >
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023 ↗
 
Via Benzinga
News headline image
Analyzing Apollo Endosurgery's Short Interest ↗
Apollo Endosurgery's (NASDAQ:APEN) short percent of float has fallen 63.08% since its last report. The company recently reported that it has 425 thousand shares sold short, which is 1.2% of all regular... 
Via Benzinga
News headline image
10 Best Stock Traders In Congress In 2022 (Spoiler: Nancy Pelosi Isn't No. 1) ↗
A new report was out about the performance of members of the U.S. Congress who bought and sold stocks and options in 2022. The report broke down unusual trading activity from members of Congress and... 
Via Benzinga
News headline image
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023 ↗
 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today ↗
 
Via Benzinga
Here's How Much $100 Invested In Apollo Endosurgery 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Apollo Endosurgery to be Acquired by Boston Scientific
Via ACCESSWIRE
News headline image
Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022
Via ACCESSWIRE
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022 ↗
 
Via Benzinga
News headline image
Short Volatility Alert: Apollo Endosurgery, Inc. ↗
On Friday, shares of Apollo Endosurgery, Inc. (NASDAQ: APEN) experienced volatile short activity. After the activity, the stock price went down -5.29% to $5.29. The overall sentiment for APEN has been... 
Via Benzinga
News headline image
Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami
Via ACCESSWIRE
News headline image
APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Investors Liked These 2 Stock Buyouts Tuesday ↗
Market performance was mixed as investors prepared for more insight on interest rates. 
Via The Motley Fool
News headline image
Nasdaq Down 50 Points; Crude Oil Rises Over 1% ↗
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 50 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Apollo Endosurgery: Q2 Earnings Insights ↗
Apollo Endosurgery (NASDAQ:APEN) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Apollo Endosurgery (NASDAQ: APEN) Enters Into Agreement to be Acquired by Boston Scientific (NYSE: BSX) for $615 Million
Apollo Endosurgery, Inc. (NASDAQ: APEN) is a medical technology company, which is focused on the research and development of advanced, 
Via Spotlight Growth
News headline image
Why Is Otonomy (OTIC) Stock Up 97% Today? ↗
Otonomy (OTIC) stock is on the move Tuesday with heavy trading despite a lack of news from the biopharmaceutical company. 
Via InvestorPlace
News headline image
US Stocks Turn Lower; Dow Falls Over 100 Points ↗
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday. 
Via Benzinga
News headline image
Bed Bath & Beyond (BBBY) Stock Rebounds After Black Friday Woes ↗
Bed Bath & Beyond (BBBY) stock is bouncing back on Tuesday after the retail company's shares took a dive Monday on poor Black Friday sales. 
Via InvestorPlace
News headline image
Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal ↗
Apollo Endosurgery is about to be acquired by Boston Scientific. Here's what this new deal means for BSX and for APEN stock. 
Via InvestorPlace
News headline image
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3 loss of $0.18 per share. 
Via Benzinga
News headline image
US Stocks Edge Higher Following Monday's Sell-Off ↗
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining more than 30 points on Tuesday. The blue-chip index dropped around 500 points on Monday. 
Via Benzinga
News headline image
APEN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apollo Endosurgery, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning! It's time for another dive into the biggest pre-market stock movers with the shares rising and falling on Tuesday! 
Via InvestorPlace
News headline image
Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.
Via ACCESSWIRE
News headline image
Apollo Endosurgery to Participate in Upcoming Investor Conferences
Via ACCESSWIRE
News headline image
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
Via ACCESSWIRE
< Previous 1 2 3 Next >